- Home
- GCBC vs ZBIO Comparison
GCBC vs ZBIO Comparison
Compare GCBC & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCBC
- ZBIO
- Stock Information
- Founded
- GCBC 1889
- ZBIO 2019
- Country
- GCBC United States
- ZBIO United States
- Employees
- GCBC N/A
- ZBIO N/A
- Industry
- GCBC Banks
- ZBIO
- Sector
- GCBC Finance
- ZBIO
- Exchange
- GCBC Nasdaq
- ZBIO NYSE
- Market Cap
- GCBC 364.4M
- ZBIO 389.2M
- IPO Year
- GCBC 1998
- ZBIO 2024
- Fundamental
- Price
- GCBC $21.61
- ZBIO $9.55
- Analyst Decision
- GCBC
- ZBIO Strong Buy
- Analyst Count
- GCBC 0
- ZBIO 7
- Target Price
- GCBC N/A
- ZBIO $32.29
- AVG Volume (30 Days)
- GCBC 27.7K
- ZBIO 131.3K
- Earning Date
- GCBC 07-22-2025
- ZBIO 05-15-2025
- Dividend Yield
- GCBC 1.62%
- ZBIO N/A
- EPS Growth
- GCBC 16.07
- ZBIO N/A
- EPS
- GCBC 1.67
- ZBIO N/A
- Revenue
- GCBC $69,414,000.00
- ZBIO $15,000,000.00
- Revenue This Year
- GCBC N/A
- ZBIO N/A
- Revenue Next Year
- GCBC N/A
- ZBIO N/A
- P/E Ratio
- GCBC $13.17
- ZBIO N/A
- Revenue Growth
- GCBC 7.46
- ZBIO N/A
- 52 Week Low
- GCBC $20.00
- ZBIO $5.83
- 52 Week High
- GCBC $37.25
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- GCBC 42.80
- ZBIO N/A
- Support Level
- GCBC $21.16
- ZBIO N/A
- Resistance Level
- GCBC $22.15
- ZBIO N/A
- Average True Range (ATR)
- GCBC 0.99
- ZBIO 0.00
- MACD
- GCBC -0.13
- ZBIO 0.00
- Stochastic Oscillator
- GCBC 15.63
- ZBIO 0.00
About GCBC Greene County Bancorp Inc.
Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.